系统性红斑狼疮成人纵向疾病活动度的遗传位点鉴定
研究纳入538例系统性红斑狼疮患者,基于SLEDAI-2K衍生的调整平均SLEDAI-2K与糖皮质激素(AMSG)评分开展全基因组关联研究,鉴定出染色体2上AGAP1内含子区rs4561613与AMSG达到全基因组显著关联(Beta=0.34,SE=0.06,P=4.16×10-9)。共定位分析未发现该位点与基因表达存在显著差异,干扰素基因评分与AMSG显著相关(Beta=0.02,SE=8.70×10-3,P=0.006)。
要点
- Meta-GWAS发现AGAP1内含子区rs4561613与AMSG全基因组显著关联(Beta=0.34,P=4.16×10-9)。
- 共定位分析未发现top SNP与多组织基因表达存在显著差异。
- 干扰素基因评分与AMSG显著相关(Beta=0.02,P=0.006)。
核心结论
- 研究鉴定出AGAP1内含子区一个全基因组显著位点,与以AMSG衡量的SLE疾病活动负荷相关。
研究设计与样本
- 纳入某三级保健狼疮门诊的SLE参与者,符合ACR和/或SLICC分类标准,在三种芯片之一上完成基因分型,且有≥3次SLEDAI-2K测量以计算AMSG评分。
- 对AMSG开展全基因组关联研究(GWAS),校正性别与5个主成分,按芯片分层后行Meta分析(P<5×10-8)。
- Meta-GWAS结果用于与多组织表达数量性状位点进行共定位分析;在部分患者中检查AMSG首位SNP与干扰素刺激基因表达的关联。
- 队列共538例SLE患者(88%为女性),诊断时中位年龄30.7岁(四分位距=23.3,41.7岁)。
主要发现
- 75%的患者在SLE诊断后1年内首次就诊,平均随访4.5年(SD=0.95)。
- AMSG中位数为5.5(Q25,Q75=3.2,8.8)。
- Meta-GWAS鉴定出染色体2上AGAP1内含子区rs4561613与AMSG全基因组显著关联(Beta=0.34,SE=0.06,P=4.16×10-9)。
- 共定位分析未发现首位SNP与基因表达存在显著差异。
- 干扰素基因评分与AMSG显著相关(Beta=0.02,SE=8.70×10-3,P=0.006)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Genetics significantly impacts systemic lupus erytematosus (SLE) risk, disease manifestations, and damage. Our aim was to identify genetic risk loci for disease activity burden over time. METHODS: We included participants from a tertiary care lupus clinic. Participants met ACR and/or SLICC classification criteria for SLE, were genotyped on one of three arrays and had ≥3 measures of disease activity [SLEDAI 2000 (SLEDAI-2K)] to derive adjusted mean SLEDAI-2K and glucocorticoid (AMSG) scores. We completed a genome-wide association study (GWAS) of AMSG, adjusted for sex and five PCs, and stratified by array, then meta-analysed GWAS (P < 5 × 10-8). Meta-GWAS results were used in colocalization analyses with expression quantitative trait loci in multiple tissues. In a subset of patients, we examined the association between the top single nucleotide polymorphism (SNP) for AMSG and interferon-stimulated gene expression. RESULTS: The cohort included 538 individuals with SLE (88% female), with a median age at diagnosis of 30.7 years (interquartile range = 23.3, 41.7 years). Most patients (75%) had a first clinic visit within 1 year of SLE diagnosis and were followed for a mean of 4.5 years (SD = 0.95). The median AMSG was 5.5 (Q25, Q75 = 3.2, 8.8). Meta-GWAS identified a genome-wide significant SNP for AMSG (rs4561613) on chromosome 2, intronic to AGAP1 (Beta = 0.34, SE = 0.06, P = 4.16 × 10-9). Colocalization analysis did not identify a significant difference in gene expression for the top SNP. Interferon gene scores were significantly associated with AMSG (Beta = 0.02, SE = 8.70 × 10-3, P = 0.006). CONCLUSION: We identified a genome-wide significant locus intronic to AGAP1 for SLE disease activity burden as measured by AMSG.
引用
- Misztal MC, Liao F, Gold N, et al. Identified genetic locus for longitudinal disease activity in adults with systemic lupus erythematosus. Rheumatology (Oxford). 2025. PMID: 40036173. doi:10.1093/rheumatology/keaf093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。